Conference & Congress Abstracts

(peer-reviewed and published abstracts, 2022 onwards)

  1. Lisocabtagene maraleucel demonstrates superior efficacy across inflammatory risk subgroups in second-line large B-Cell Lymphoma: a retrospective analysis of the TRANSFORM study. American Society of Hematology Annual Symposium, 2025 [abstract achievement award] Ray, Pradipta et al, Blood, 146 (Supp 1):3549, 2025

  2. INSIGHT: A baseline laboratory profile independently predicts outcomes and demonstrates superiority of lisocabtagene maraleucel (liso-cel) over standard of care (SOC) in second-line (2L) large B-cell lymphoma (LBCL) regardless of baseline profile. American Society of Hematology Annual Symposium, 2025. Ansari, Sahar et al, Blood, 146 (Supp 1):1775, 2025

  3. Circulating tumor DNA levels and related kinetics as prognostic biomarkers for clinical outcomes in mCRPC: A post hoc analysis of CM 7DX, American Society of Clinical Oncology Genitourinary Cancers Annual Symposium, 2025. Fizazi, Karim et al, Journal of Clinical Oncology 43(5, suppl): 252-252, 2025

  4. Propensity score (PS) comparison between lisocabtagene maraleucel (liso-cel) plus ibrutinib combination therapy (combo) and liso-cel monotherapy (mono) cohorts from TRANSCEND CLL, American Society of Clinical Oncology Annual Meeting, 2025. Wierda, William et al, Journal of Clinical Oncology, 43 (16, suppl): 7037, 2025

  5. Characteristics Associated With Response to Lisocabtagene Maraleucel (liso-cel) in Patients With R/R CLL/SLL: Exploratory Analyses From the Phase 1/2 TRANSCEND CLL 004 Study, European Hematology Association Annual Meeting, 2024 Encored at: Society of Hematologic Oncology Annual Meeting, 2024 Wierda, William et al, Clinical Lymphoma Myeloma and Leukemia, 24 (Supp 1): S346, 2024

  6. RRMM and Post-BCMA Treated Subjects from the CC-220-MM-001 Study Show Increased Genomic Aberrations Associated with High-Risk and Significant Dysfunction in CD4+ T-Cell Compartment Compared to NDMM Subjects, American Society of Hematology Annual Meeting, 2023. Amatangelo, Michael et al, Blood 142 (Supp 1): 4665, 2023

  7.  Oncostatin M Induces Nociceptive Signaling In Human Dorsal Root Ganglia, US Association for the Study of Pain Annual Meeting, 2023. Mwirigi, Juliet et al, Pain 24 (4 Supp): 16, 2023

  8. Discovery of pain-associated neuro-immune protein interaction networks from sex differential neuronal and immune gene expression profiles in human DRGs, Peripheral Nerve Society Annual Meeting, 2022. Ray, Pradipta et al., Journal of the Peripheral Nervous System, 27 (S3), 2022

  9. Interactions between human peripheral sensory neurons and immune cells, Peripheral Nerve Society Annual Meeting, 2022. Tavares-Ferreira, Diana et al., Journal of the Peripheral Nervous System, 27 (S3), 2022

  10.  Molecular characterization of human dorsal root ganglion using spatial RNA sequencing and RNAScope in-sity hybridization, Peripheral Nerve Society Annual Meeting, 2022. Shiers, Stephanie et al, Journal of the Peripheral Nervous System, 27 (S3), 2022